Abstract
We report a 32-year-old man with herpes simplex virus encephalitis who developed massive pulmonary thromboembolism with mobile right atrial thrombi during treatment for this condition. It was not safe to use thrombolytic therapy because of the high risk of cerebral bleeding associated with encephalitis. The patient was initially treated at another center, but his condition deteriorated during nadroparin therapy and he was referred to our hospital. Nadroparin was discontinued, and a continuous infusion of unfractionated heparin was administered through a central venous catheter. The patient's general status improved over the next 24 hours, and all thrombi in the right atrium disappeared. There was immediate lysis of the thrombi after the continuous infusion of unfractionated heparin was initiated. We suggest that central-line infusion of this agent is preferable to peripheral infusion in such cases. Further research on the potential thrombolytic effect of heparin is needed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Heart & Lung - The Journal of Acute and Critical Care
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.